Trials that use: Mixed-effects model
New to this method? Read the tutorial →
279 results
- Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?: Complete Statistical AnalysisIndependent statistical analysis of Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DysmenorrheaIndependent statistical analysis of Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00517556).
- EASE SBS 1Independent statistical analysis of Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning: Complete Statistical AnalysisIndependent statistical analysis of Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00611975).
- Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin: Complete Statistical AnalysisIndependent statistical analysis of Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Effect of Energy Density Over 5 Days in Preschool Children: Complete Statistical AnalysisIndependent statistical analysis of Effect of Energy Density Over 5 Days in Preschool Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03010501).
- Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014): Complete Statistical AnalysisIndependent statistical analysis of Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients: Complete Statistical AnalysisIndependent statistical analysis of Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Effects of a Patient Portal Intervention to Address Diabetes Care Gaps: Complete Statistical AnalysisIndependent statistical analysis of Effects of a Patient Portal Intervention to Address Diabetes Care Gaps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Effects of Probiotic and Prebiotic Combinations on Premature Infants: Complete Statistical AnalysisIndependent statistical analysis of Effects of Probiotic and Prebiotic Combinations on Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282113).
- Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma: primary endpoint results, effect estimate with confidence interval,…
- Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy and Safety Study in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00980200).
- Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications: primary endpoint results, effect estimate with confidence…
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00730691).
- Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to…
- EMBRACAIndependent statistical analysis of the EMBRACA phase 3 trial of talazoparib versus physician's choice treatment in advanced and/or metastatic breast cancer patients with BRCA mutation, including progression-free survival, response, overall survival, quality…
- EMBRACEIndependent statistical analysis of Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04252742).
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): Complete Statistical AnalysisIndependent statistical analysis of EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPEROR-ReducedIndependent statistical analysis of EMPEROR-Reduced, a randomized phase 3 trial of empagliflozin versus placebo in chronic heart failure with reduced ejection fraction. Includes the registered time-to-event endpoint, Cox and mixed-effects analyses, reported…
- Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Estrogen Variability and Irritability During the Menopause Transition: Complete Statistical AnalysisIndependent statistical analysis of Estrogen Variability and Irritability During the Menopause Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05388656).
- Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of a Mental Health Physician Support Program in Nova Scotia: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Mental Health Physician Support Program in Nova Scotia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Astigmatic Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Astigmatic Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03086447).
- Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Robotic Arm Rehabilitation in Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Robotic Arm Rehabilitation in Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00333983).
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Aevidum Curriculum and Club: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Aevidum Curriculum and Club: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05018689).
- Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04186806).
- Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EVOLVE-1Independent statistical analysis of the phase 3 EVOLVE-1 trial of galcanezumab for the prevention of episodic migraine, including randomized design, longitudinal mixed-effects analysis, odds ratios, Fisher exact testing, efficacy results, safety, and…
- Exercise and QUality Diet After Leukemia: The EQUAL Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise and QUality Diet After Leukemia: The EQUAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244411).
- EXTENDIndependent statistical analysis of Exercise Effects on Brain Health and Learning From Minutes to Months: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FACT OA1Complete statistical analysis of the phase 3 FACT OA1 trial of fasinumab versus placebo and naproxen for pain from osteoarthritis of the knee or hip, including trial design, WOMAC endpoints, mixed-effects modeling,…
- Fatty Acid Oxidation Defects and Insulin Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Fatty Acid Oxidation Defects and Insulin Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02517307).
- FINEARTS-HFIndependent statistical analysis of FINEARTS-HF, the randomized phase 3 trial evaluating finerenone versus placebo in participants with heart failure and left ventricular ejection fraction greater than or equal to 40%.
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): Complete Statistical AnalysisIndependent statistical analysis of Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): primary endpoint results, effect estimate with confidence…
- FX-LEARNIndependent statistical analysis of AFQ056 for Language Learning in Children With FXS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02920892).
- GALACTIC-HFIndependent statistical analysis of GALACTIC-HF, the randomized phase 3 trial of omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, including time-to-event methods, KCCQ analysis, confidence intervals, multiplicity, and safety.
- GALATHEAIndependent statistical analysis of the phase 3 GALATHEA trial of benralizumab 30 mg and 100 mg versus placebo in moderate to very severe COPD with exacerbation history, covering negative binomial exacerbation-rate ratios,…